Correlation Between Oncology Institute and NewGenIvf Group

Can any of the company-specific risk be diversified away by investing in both Oncology Institute and NewGenIvf Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncology Institute and NewGenIvf Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between The Oncology Institute and NewGenIvf Group Limited, you can compare the effects of market volatilities on Oncology Institute and NewGenIvf Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncology Institute with a short position of NewGenIvf Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncology Institute and NewGenIvf Group.

Diversification Opportunities for Oncology Institute and NewGenIvf Group

-0.3

Correlation Coefficient

Oncology Institute  NewGenIvf Group

Very good diversification

The 3 months correlation between Oncology and NewGenIvf is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding The Oncology Institute and NewGenIvf Group Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewGenIvf Group and Oncology Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Oncology Institute are associated (or correlated) with NewGenIvf Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewGenIvf Group has no effect on the direction of Oncology Institute i.e., Oncology Institute and NewGenIvf Group go up and down completely randomly.

Pair Corralation between Oncology Institute and NewGenIvf Group

Assuming the 90 days horizon Oncology Institute is expected to generate 15.5 times less return on investment than NewGenIvf Group. But when comparing it to its historical volatility, The Oncology Institute is 1.3 times less risky than NewGenIvf Group. It trades about 0.02 of its potential returns per unit of risk. NewGenIvf Group Limited is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  2.10  in NewGenIvf Group Limited on October 5, 2024 and sell it today you would earn a total of  1.84  from holding NewGenIvf Group Limited or generate 87.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	85.0%
Values	Daily Returns

The Oncology Institute  vs.  NewGenIvf Group Limited

The Oncology Institute

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in The Oncology Institute are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Oncology Institute showed solid returns over the last few months and may actually be approaching a breakup point.

NewGenIvf Group

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NewGenIvf Group Limited are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, NewGenIvf Group showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oncology Institute and NewGenIvf Group

The main advantage of trading using opposite Oncology Institute and NewGenIvf Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncology Institute position performs unexpectedly, NewGenIvf Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewGenIvf Group will offset losses from the drop in NewGenIvf Group's long position.

The idea behind The Oncology Institute and NewGenIvf Group Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.